Dr. Cristianne Rijcken is the founder of Cristal Therapeutics, and serves as Chief Scientific Officer of the company. Dr. Rijcken’s PhD thesis provided a strong basis for Cristal Therapeutics and she was awarded multiple grants and prizes including the Simon Stevin Gezel Award in 2008 and the Knowledge for Growth Inspiring Young Scientist Award in 2014. She is (co-) author of 28 scientific publications and co-inventor of all patents and patent applications of Cristal Therapeutics. Previously, Dr. Rijcken was actively involved in management of several other companies, including BellMed. Dr. Rijcken is pharmacist by training and holds a PhD degree in Pharmaceutics from Utrecht University.
Dr. Rijcken can be reached via email: email@example.com